 RESEARCH TRIANGLE PARK, N.C., Jan. 05, 2021 GLOBE NEWSWIRE -- G1 Therapeutics, Inc. Nasdaq: GTHX, a clinical-stage oncology company, today announced that Chief Executive Officer Jack Bailey will present a company update at the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021 at 2:50 p.m. ET. 